Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study

Source: Journal of Reproductive Immunology - Category: Allergy & Immunology Authors: Source Type: research